Evidence map›Paper›PMID 33897872›Full record

ArticleTheranostics2021

An exosomal-carried short periostin isoform induces cardiomyocyte proliferation.

Carolina Balbi, Giuseppina Milano, Tudor E Fertig, Edoardo Lazzarini, Sara Bolis, Yoshiaki Taniyama, Fumihiro Sanada, Dario Di Silvestre, Pierluigi Mauri, Mihaela Gherghiceanu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Monocyte-derived exosomal periostin driven by histone lactylation contributes to retinal neovascularization.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The role of periostin in cardiac fibrosis.Heart failure reviews · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Signaling pathways and targeted therapy for myocardial infarction.Signal transduction and targeted therapy · 2022
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Carolina BalbiLaboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland.
Giuseppina MilanoLaboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland.
Tudor E FertigVictor Babes National Institute of Pathology, Bucharest, Romania.
Edoardo LazzariniLaboratory for Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Lugano, Switzerland.
Sara BolisLaboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland.
Yoshiaki TaniyamaDepartment of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Fumihiro SanadaDepartment of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Dario Di SilvestreProteomics and Metabolomic Lab, ITB-CNR, Segrate, Italy.
Pierluigi MauriProteomics and Metabolomic Lab, ITB-CNR, Segrate, Italy.
Mihaela GherghiceanuVictor Babes National Institute of Pathology, Bucharest, Romania.
Thomas F LüscherCenter for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
Lucio BarileLaboratory for Cardiovascular Theranostics, Istituto Cardiocentro Ticino, Lugano, Switzerland.
Giuseppe VassalliLaboratory of Cellular and Molecular Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland.
University of Zurich · CHInstitute of Biomedical Technologies · ITInstitutul National Victor Babes · ROOsaka University · JPScuola Superiore Sant'Anna · ITUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although a small number of cardiomyocytes may reenter the cell cycle after injury, the adult mammalian heart is incapable of a robust cardiomyocyte proliferation. Periostin, a secreted extracellular matrix protein, has been implicated as a regulator of cardiomyocyte proliferation; however, this role remains controversial. Alternative splicing of the human periostin gene results in 6 isoforms lacking sequences between exons 17 and 21, in addition to full-length periostin. We previously showed that exosomes (Exo) secreted by human cardiac explant-derived progenitor cells (CPC) carried periostin. Here, we aimed to investigate their cell cycle activity.

Indexed as

AgedAged, 80 and overAnimalsCell Adhesion MoleculesCell CycleCell ProliferationCells, CulturedExosomesFemaleHumansInduced Pluripotent Stem CellsMaleMiddle AgedMyocardial InfarctionMyocytes, CardiacProtein IsoformsCell Adhesion MoleculesPOSTN protein, humanProtein Isoformscardiomyocyteexosomesextracellular vesiclesHippo pathwayisoformsperiostinproliferation

Identifiers

PMID33897872
PMCPMC8058720
OpenAlexW3154031290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.